Carboplatin
Overview
Carboplatin is a chemotherapy medication used to treat various types of cancer. It is a platinum-based compound that interferes with the DNA of cancer cells, inhibiting their growth and division.
API suppliers (15)
Suppliers of Carboplatin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 10 of 15 suppliers.
6 of 15 hold a GMP certificate on record in the EU or UK registers
- TAPI NL BVNetherlands1 active DMF
- Laurus Labs LimitedIndia1 active DMF GMP on record
- UMICORE ARGENTINA SA1 active DMF
- Hetero Labs LimitedIndia1 active DMF GMP on record
- KUNMING GUIYAN PHARMACEUTICAL CO LTDChina1 active DMF
- VERANOVA LPUnited Kingdom1 active DMF
- HERAEUS PRECIOUS METALS GMBH AND CO KGGermany1 active DMF
- Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
- Qilu Pharmaceutical Co., Ltd.China1 active DMF GMP on record
- FRESENIUS KABI ONCOLOGY LTDIndia GMP on record
- PLIVA-LACHEMA AS
- MAC CHEM PRODUCTS INDIA PVT LTD GMP on record
- LACHEMA BRNO
- INSTITUTE DRUG TECHNOLOGY AUSTRALIA LTD
- Cipla USA, Inc.USA
Patent & exclusivity (US)
Per the FDA Orange Book (47 approved US products), the latest listed US patent on Carboplatin expires 1 Apr 2045. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Carboplatin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.